+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Pruritus - Pipeline Insight, 2025 - Product Thumbnail Image

Pruritus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chronic Urticaria Or Hives - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Urticaria Or Hives - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Severe Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2025 - Product Thumbnail Image

Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Rosacea - Pipeline Insight, 2025 - Product Thumbnail Image

Rosacea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Contact Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Insight, 2025 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Xerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Xerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
From
Chronic Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acne Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Acne Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Common Warts - Pipeline Insight, 2025 - Product Thumbnail Image

Common Warts - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Deep Partial-Thickness Thermal Burns - Pipeline Insight, 2025 - Product Thumbnail Image

Deep Partial-Thickness Thermal Burns - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hidradenitis Suppurativa - Pipeline Insight, 2025 - Product Thumbnail Image

Hidradenitis Suppurativa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
Dyschromia - Pipeline Insight, 2025 - Product Thumbnail Image

Dyschromia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Cholestatic Pruritus- Pipeline Insight, 2025 - Product Thumbnail Image

Cholestatic Pruritus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more